Emerging role of Saikosaponin A in tumor therapy and tumor microenvironment immunomodulation

Lijie Zhang1, Chunjian Wang2, Xizhong Zhang2

  • 1Key Laboratory of Immune Microenvironment and Inflammatory Disease Research in Universities of Shandong Province, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, Shandong 261053, PR China.

Saikosaponin A(SSA), a type of saponin compound, is extracted from Bupleurum and is the main active component of this plant. Recent studies have shown that SSA plays important roles in tumor therapy and tumor microenvironment (TME) immunomodulation. Although many new experimental studies on SSA in tumor treatment and immune regulation have been reported, the reviews about its role in tumor treatment and TME are relatively limited. Therefore, this review elaborates the anti-tumor effects of SSA in tumors and their potential mechanisms, including anti-proliferation, induction of apoptosis and ferroptosis, inhibition of metastasis, anti-angiogenesis, inhibition of glycolysis and drug resistance, etc. Moreover, this review reveals the roles of SSA in the TME, points out its regulation on tumor immune cells and cytokines, and clarifies the advantages, limitations and challenges of SSA in tumor treatment. In conclusion, this review summarizes the roles of SSA in tumor treatment and TME regulation, and analyzes the application prospects and challenges of SSA in cancer therapy, which will provide new directions and theoretical basis for clinical cancer treatment.

Related Concept Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical...
10.1K
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies10:13

A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies

Many types of human brain tumors are localized to specific regions within the brain and are difficult to grow in culture. This protocol addresses the role of tumor microenvironment and investigates new drug treatments by analyzing fluorescent primary brain tumor cells growing in an organotypic mouse brain slice.
11.6K
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors08:32

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Here we describe a method to separate and enrich components of the tumor immune and non-immune microenvironment in established subcutaneous tumors. This technique allows for the separate analysis of tumor immune infiltrate and non-immune tumor fractions which can permit comprehensive characterization of the tumor immune...
10.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Glioblastoma is the most common and aggressive primary brain malignancy in adults, with most tumors recurring after initial treatment. Tumor Treating Fields (TTFields) therapy is the newest treatment modality for glioblastoma. Here, we describe the proper application of TTFields-transducer arrays on patients and discuss theory and aspects of...
19.1K
Microfluidic Device for Recreating a Tumor Microenvironment in Vitro16:18

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro

We present the procedure for fabrication and operation of a microfluidic device that recreates heterogeneous tumor microenvironments in vitro. The variability in apoptosis within tumor tissue was quantified using fluorescent stains and the effective diffusion coefficient of the chemotherapeutic drug doxorubicin into tumor tissue was...
12.0K